Latest Regulatory Milestones News

Titanium Sands Limited has secured one-year retentions for four high-grade exploration licenses, enabling critical environmental studies and paving the way for a mining license application in Sri Lanka.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.

PainChek Limited has secured a pivotal reseller and integration deal with Eldermark Software, positioning its AI-driven pain assessment app for a major US market rollout pending FDA approval.

Silver Mines Limited has received a key determination from the NSW Planning Secretary confirming the transmission line as part of the Bowdens Silver Project development, paving the way for progress towards final consent.

Bubalus Resources has secured heritage clearance for a key 40-hectare area at its Yinnietharra Lithium Project, paving the way for exploration drilling at the promising Malinda East target adjacent to a major lithium deposit.

Jameson Resources has announced a $3.5 million equity raise to advance its Crown Mountain Hard Coking Coal Project in British Columbia, supported by a positive feasibility update and strong government backing amid geopolitical trade tensions.

Horseshoe Metals is close to completing infrastructure upgrades at its Horseshoe Lights project, setting the stage for imminent copper Direct Shipping Ore operations and gold processing activities.

New World Resources’ Antler Copper Project in Arizona has been designated a FAST-41 Transparency Project, promising a streamlined federal permitting process and reinforcing its strategic role in US critical minerals supply.

Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.

Gold Road Resources has secured a crucial regulatory green light as the Foreign Investment Review Board approves Gold Fields’ acquisition scheme. The deal now moves closer to shareholder and court approvals.

EMVision Medical Devices has enhanced its AI-powered stroke diagnostic algorithm, achieving a notable 95% sensitivity and 80% specificity in recent tests. This progress sets the stage for upcoming pivotal trials and regulatory milestones.